Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2017 2018 2019 2020 2021 2022 2023 2024 2025

Gene Research and Development

         

Research, Development and Commercialization of its Novel Gene Therapies

- - 60.36L 40.55L 44.13L

Total Assets

11Cr 11Cr 6.45Cr 8.24Cr 4.35Cr

Interest Expense

-79T - - - -51.88L

Income Tax Expense

-52T - - - -

CAPEX

-10.66L -44.57L -1.05Cr -33.85L -2L

EBT

-5.84Cr -8.14Cr -6.31Cr -5.41Cr -6.78Cr

D&A

2L 5L 7L 19.68L 23.89L

Operating Income

-5.8Cr -8.49Cr -6.55Cr -5.48Cr -6.29Cr

Net Income

-5.84Cr -8.14Cr -6.31Cr -5.41Cr -6.78Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States

- - 60.36L 40.55L 44.13L

Total Assets

11Cr 11Cr 6.45Cr 8.24Cr 4.35Cr

Interest Expense

-79T - - - -51.88L

Income Tax Expense

-52T - - - -

D&A

2L 5L 7L 19.68L 23.89L

CAPEX

-10.66L -44.57L -1.05Cr -33.85L -2L

Net Income

-5.84Cr -8.14Cr -6.31Cr -5.41Cr -6.78Cr

EBT

-5.84Cr -8.14Cr -6.31Cr -5.41Cr -6.78Cr

Operating Income

-5.8Cr -8.49Cr -6.55Cr -5.48Cr -6.29Cr